Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease - Wikidata - awgldk - TriplyDB

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

http://www.wikidata.org/entity/Q28195845

about

The promise of neuroprotective agents in Parkinson's disease Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis An overview of clinical pharmacology of Ibuprofen Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies Use of ibuprofen and risk of Parkinson disease Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs Gene-environment interactions: key to unraveling the mystery of Parkinson's disease Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.Formulations of hormone therapy and risk of Parkinson's disease.Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.The endotoxin-induced neuroinflammation model of Parkinson's disease.The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation.Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.Death in the substantia nigra: a motor tragedy.Parkin deficiency increases vulnerability to inflammation-related nigral degeneration Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.Targets for neuroprotection in Parkinson's disease Microglial ion channels as potential targets for neuroprotection in Parkinson's disease.Innate and adaptive immunity for the pathobiology of Parkinson's disease Autoimmune disease and risk for Parkinson disease: a population-based case-control study.Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction.Pharmacological therapy in Parkinson's disease: focus on neuroprotection.Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?Parkinson's disease: evidence for environmental risk factors.The role of inflammation in sporadic and familial Parkinson's disease.The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration

P2860

Q21129436-CD017E07-2679-47D4-97AA-19744A4ABE55 Q22241651-ECE02050-DECC-444A-88AA-1DB3F76170A8 Q23724883-7188F56A-83BC-4B7F-9B23-FCE695AFEE72 Q24235107-704BF040-D851-4E6E-862B-75362BEF25DF Q24594751-16F1F72D-51B2-40BC-92BD-4CC5937A6ED8 Q26795984-7583A1AD-5EC3-4245-9CAD-826D4933200B Q26801035-694D96E4-A83B-4284-A4FB-59E7391B6DF9 Q28388674-00682A72-0A60-4EB2-B259-57DA274C51DF Q28392767-CBDB0F58-109C-4EE8-B101-E42A79B5324B Q28397422-34D57E2C-558A-4751-B6AC-2D67FF037BAA Q28476681-C67BAC5B-2416-41FA-9E97-40CA19BBD999 Q29547835-BA8550F1-43A4-4687-BA12-1ACE34B06353 Q33836942-B802CFB9-F6F1-4538-B4D4-7814C27A9CD1 Q34353167-B40989B6-3F0F-48D8-BD35-3FACCBE38E4D Q34437648-0EC1675E-85A7-419D-8ED3-7B061FD1BCFF Q34505182-332249A3-0EE5-4ACD-AF89-7E299B16C983 Q34557246-375AA24C-15C4-4906-BD62-AD2B5AEB4E76 Q36048230-C1CC8BCB-B54C-4154-84B8-B4745668969C Q36453886-A5821670-78AC-4232-ACB9-AC5DC489DE12 Q36537780-1FA4477D-B0B1-4099-B5C0-11B5D918D03A Q36773965-415466AB-715F-406C-898B-A6115363F1B1 Q36847262-30485C7F-5099-433B-BA80-EBE7F7220248 Q37015945-589F4FAA-E536-40E6-921B-9AFD73BD7D15 Q37069901-DA5E6A84-D541-48BF-922D-A56702136A27 Q37241917-A231F78E-93E5-41B8-BB61-C2E3E2896464 Q37267160-A48FEB33-27B3-4F0B-96BC-D9BB0018602C Q37302453-A48E27B0-010E-414F-A096-BF4F5AB32DB9 Q37322333-45B17C08-7DFB-4597-BA3E-DAE89239D53D Q37401280-79682BC5-2326-47F3-8E94-5DC975F59F78 Q37425099-2CCAA1CA-0520-411A-8F86-E6270AB0192B Q37680121-7F060524-3926-4C85-B70A-A221F0C225C9 Q37741285-E4EE09D1-5DC1-4F66-AF5F-B5AA5443F484 Q37878282-A2BB782D-0EC4-403F-BE54-992B3B660374 Q37886152-D8A83421-8A61-47A0-8BA1-9FCCAC944E4D Q38055457-E9C1CBE1-D4A0-4C80-9146-D16C2FED58EB Q38105903-53AD6165-79E1-457A-BE8F-20BD190A1FB5 Q38115703-A675F097-B523-4E3A-B950-49EED3CFE865 Q38693732-BC3FB94C-578F-4856-9739-35F557519AB3 Q38784992-11A45DB2-0A65-4BCC-8114-E5FB937AA2F7 Q38860761-523198E8-BC87-493A-9DBC-908A7B6F595F

P2860

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

http://www.wikidata.org/entity/Q28195845

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@ast

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@en

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@nl

type

label

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@ast

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@en

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@nl

prefLabel

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@ast

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@en

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@nl

P1433

Q28195845-0B9762B4-8D7B-4D20-8BA6-5DB7110FE4E2

P1476

Q28195845-C3BDF77C-E500-451B-A403-1905624E4467

P2093

Q28195845-1AE6F44F-D9D9-4E62-9DF3-706408DF3EF7

Q28195845-1BEE53E2-85C0-4382-B098-1A75DAD1E11B

Q28195845-28BA0B23-E2F1-4C18-95D6-A6B289A6C132

Q28195845-58062F3E-2231-4F55-B478-13F5D56573A7

Q28195845-5A28C712-4176-4A35-8B19-34068F608F79

Q28195845-739A61DA-095F-4B33-B1CE-D8D09B82E476

Q28195845-9F42EEEA-C518-480C-A23D-A94CCFAB8403

Q28195845-F2D2B196-6412-443B-8EDA-AACDE30F3D56

P2860

Q28195845-5CAD41D2-3D42-46DB-8E12-88DD6E6F18DA

Q28195845-64B839C0-31E3-44DA-9670-30F26F42C7D8

Q28195845-9212D5F9-6624-48AF-8812-F8B6A665EAEC

Q28195845-93C1651F-4C0A-4BBB-8685-B2D742AA6FDB

Q28195845-B4E532D5-A718-4255-BFEF-8E0D7716F03D

Q28195845-C35C6565-5652-4F8F-8AFA-DDB2558D6270

Q28195845-C89AB98A-8CF9-4DE7-B9FE-573F7D0004C4

Q28195845-D217E2D2-2EBA-49B7-A91D-F3588379DD08

Q28195845-E6B656E0-949C-423C-A2FF-49EFA4B91691

Q28195845-EA7F2A26-7520-46A5-99B5-82704D45C29C

P304

Q28195845-86F38870-FFDD-4655-A56A-A65D671D7B47

P31

Q28195845-73DE3E8B-6A04-420D-AA7E-9545B27E92FD

P356

Q28195845-0964AA3C-B47D-4A51-AC65-FBA30398D8DA

P407

Q28195845-44798018-2B67-446A-97BD-C0AB0B9584A9

P433

Q28195845-55B2E6AF-59BC-43D7-AE35-2E590BFAA63C

P478

Q28195845-38986D2C-632F-45EC-B9DA-E5781CE88261

P50

Q28195845-B3B28DA9-9DA1-4EB8-B20A-F9A151527748

P577

Q28195845-60CD9BE3-AD00-458B-A409-72555F46A1CE

P698

Q28195845-C4E717F6-9937-410A-997B-DB99E4F3F313

P921

Q28195845-041F6A16-C241-48B0-81B3-D6C867891CAF

Q28195845-7C1CC11A-0DD5-4DE8-99AF-359F3CB3F202

P356

P1433

Movement Disorders

P1476

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

@en

P2093

Gary M Franklin

http://www.w3.org/2001/XMLSchema#string

Harvey Checkoway

http://www.w3.org/2001/XMLSchema#string

Mary Anne Rossing

http://www.w3.org/2001/XMLSchema#string

Phillip D Swanson

http://www.w3.org/2001/XMLSchema#string

Susan R Heckbert

http://www.w3.org/2001/XMLSchema#string

Terri Smith-Weller

http://www.w3.org/2001/XMLSchema#string

Thanh G Ton

http://www.w3.org/2001/XMLSchema#string

W T Longstreth

http://www.w3.org/2001/XMLSchema#string

P2860

Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

Parkinson's disease: mechanisms and models

Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

The risk of myocardial infarction associated with antihypertensive drug therapies.

Cytokines in neurodegeneration and repair.

Cyclooxygenases and the central nervous system.

Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice.

P304

964-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.20856

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Walter A. Kukull

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16550541

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease